$1.97
▼ $-0.07
(-3.43%)
Vol 135K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$94.4M
ROE
-148.8%
Margin
-19.6%
D/E
0.00
Beta
2.03
52W
$0–$2
Wall Street Consensus
12 analysts · Apr 20265
Strong Buy
5
Buy
2
Hold
0
Sell
0
Strong Sell
83.3%
Buy Rating
Price Chart
Similar Stocks
SPRO
Spero Therapeutics Inc
$131.3M
CBUS
Cibus Inc
$94.5M
BDTX
Black Diamond Therapeutics Inc
P/E 6.4
$138.4M
KLRS
Kalaris Therapeutics Inc
$141.3M
AGEN
Agenus Inc
$106.8M
HUMA
Humacyte Inc
$185.4M
IMDX
Insight Molecular Diagnostics Inc
$215.0M
PEPG
PepGen Inc
$447.6M
GNLX
Genelux Corp
$165.9M
SGMO
Sangamo Therapeutics Inc
$141.3M
Earnings
Beat rate: 100.0%
Next Report
May 12, 2026
EPS Estimate: $-0.05
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.05 | — | — |
| Dec 2025 | $-0.06 | $-0.04 | +$0.02 |
| Sep 2025 | $-0.15 | $-0.06 | +$0.09 |
| Jun 2025 | $-0.19 | $-0.16 | +$0.03 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $12.2M | $4.4M | — | — | — |
| Net Income | -$7K | -$5.8M | -$8.7M | -$5.7M | -$4.2M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -140.0% | -74.4% | -139.6% | -139.6% | -140.0% | -148.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -19.6% | -19.6% | -19.6% | -19.6% | -19.6% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 1.65 | 2.70 | 1.65 | 1.65 | 1.65 | 10.85 |
Key Ratios
ROA (TTM)
-109.5%
P/S (TTM)
2.30
P/B
1.4
EPS (TTM)
$-0.63
CF/Share
$-0.23
52W High
$2.35
52W Low
$0.27
$0.27
52-Week Range
$2.35
Financial Health
Free Cash Flow
-$8.4M
Net Debt
-$32.4M
Cash
$33.1M
Total Debt
$745K
As of Sep 30, 2025
How does EQ compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
EQ valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
2.3
▼
82%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.4
▼
43%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
EQ profitability vs Biotechnology peers
ROE
-148.8%
▼
121%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-19.6%
▲
93%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-109.5%
▼
134%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
EQ financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
10.9
▲
144%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.0
▲
109%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
EQ fundamentals radar
EQ
Peer median
Industry
EQ profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
EQ vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
ZEDELMAYER CHRISTINE
Chief Operating Officer · Mar 13
120312 shs
ZEDELMAYER CHRISTINE
Chief Operating Officer · Mar 13
120312 shs
ZEDELMAYER CHRISTINE
Chief Operating Officer · Mar 09
181219 shs
ZEDELMAYER CHRISTINE
Chief Operating Officer · Mar 09
152361 shs
ZEDELMAYER CHRISTINE
Chief Operating Officer · Feb 19
185937 shs
ZEDELMAYER CHRISTINE
Chief Operating Officer · Feb 19
185937 shs
ZEDELMAYER CHRISTINE
Chief Operating Officer · Feb 19
185937 shs
ZEDELMAYER CHRISTINE
Chief Operating Officer · Feb 19
185937 shs
TOM PENNY
Officer · Jan 08
6533 shs
Last 90 days
Top Holders
Top 5: 40.64%Janus Henderson Group PLC
9.63%
$11.0M
Adar1 Capital Management, L…
9.21%
$10.5M
Adage Capital Partners GP L…
8.75%
$10.0M
Decheng Capital LLC
7.30%
$8.4M
Woodline Partners LP
5.75%
$6.6M
As of Dec 31, 2025
Latest News
What Schwab U.S. Dividend Equity’s New Dividend Means for Investors
Yahoo Finance · Apr 05
DHS Rescinds Policy Requiring Secretary Review Of Contracts Above $100,000
ZeroHedge · Apr 05
HELOC and home equity loan rates Saturday, April 4, 2026: Low and …
Yahoo Finance · Apr 04
Stop Losing Money to Required Minimum Distributions and Use This Simple Fix
Nasdaq · Apr 04
VDC vs. RSPS: For Consumer Staples ETFs, Does Equal Weighting Beat Lower …
Nasdaq · Apr 03